Planar array electrophysiology techniques were applied to assays for modulators of recombinant hIK and hSK3 Ca 2+ -activated K + channels. In CHO-hIK-expressing cells, under asymmetric K + gradients, small-molecule channel activators evoked time-and voltage-independent currents characteristic of those previously described by classical patch clamp electrophysiology methods. In single-hole (cell) experiments, the large cell-to-cell heterogeneity in channel expression rendered it difficult to generate activator concentration-response curves. However, in population patch clamp mode, in which signals are averaged from up to 64 cells, well-to-well variation was substantially reduced such that concentration-response curves could be easily constructed. The absolute EC 50 values and rank order of potency for a range of activators, including 1-EBIO and DC-EBIO, corresponded well with conventional patch clamp data. Activator responses of hIK and hSK3 channels could be fully and specifically blocked by the selective inhibitors TRAM-34 and apamin, with IC 50 values of 0.31 µM and 3 nM, respectively. To demonstrate assay precision and robustness, a test set of 704 compounds was screened in a 384-well format of the hIK assay. All plates had Z′ values greater than 0.6, and the statistical cutoff for activity was 8%. Eleven hits (1.6%) were identified from this set, in addition to the randomly spiked wells with known activators. Overall, our findings demonstrate that population patch clamp is a powerful and enabling method for screening Ca 2+ -activated K + channels and provides significant advantages over single-cell electrophysiology (IonWorks HT ) and other previously published approaches. Moreover, this work demonstrates for the 1st time the utility of population patch clamp for ion channel activator assays and for non-voltage-gated ion channels. (Journal of Biomolecular
INTRODUCTION
I NTERMEDIATE-CONDUCTANCE (IK) and small-conductance (SK1, SK2, SK3) Ca 2+ -activated K + channels comprise a 4-member gene family in humans, with 40% to 70% sequence identity. 1, 2 These genes, named KCNN1-4, encode 6 transmembrane-domain protein subunits with intracellular N-and C-termini which tetramise, either as homomer or heteromers, to form functional K + channels. Ca 2+ dependence of these channels is conferred by calmodulin, a Ca 2+ -binding protein that is tethered to the C-terminal domain. The effective concentrations of Ca 2+ for channel activation are in the physiological intracellular free range of 30 nM to 1 µM. 1, 3 A wide range of physiological functions have been ascribed to SK and IK channels, including medium and slow afterhypolarizations in central and peripheral neurons, homeostasis in erythrocytes, a role in T-lymphocyte activation, and secretion coupling in lung and gut epithelia. [4] [5] [6] [7] [8] [9] Both activators and blockers of these channels are of interest as potentially novel therapeutics.
To date, high-throughput screening methods for these channels have been restricted to indirect measurements with fluorescent dyes or tracers. Membrane potential-sensitive redistribution probes such as oxonol dyes or coumarin-oxonol fluorescent resonance energy transfer pairs can be used but provide nonlinear readouts of channel activation and are prone to interference from autofluorescent or quenching compounds. 10 Moreover, any nonspecific membrane polarizing or disrupting agents can appear as false-positive compounds. An alternative method is to use lowaffinity Ca 2+ probes such as benzothiazole coumarin to trace Tl + as a surrogate for K + movement across the cell. However, Tl + is weakly soluble in Cl --containing buffers and is hazardous in the large quantities required for large screening campaigns. A 3rd and probably the most common approach is to measure Rb + flux, either by scintillation proximity assay ( 86 Rb + ) or atomic absorption spectroscopy (see Terstappen 11 for review).
The current gold standard method for functional analysis of SK/IK channels is patch clamp electrophysiology, which provides exquisite sensitivity and temporal resolution and is capable of resolving single-channel openings at the microsecond time scale. However, for the drug discoverer, its technical difficulty and low throughput (<10 compounds per day) have severely hampered its use as a frontline screening approach. The advent of planar array patch clamp electrophysiology [12] [13] [14] allows parallel recordings to be made from many individual cells, thus markedly increasing throughput. Indeed, it is possible to obtain recordings from more than 2000 cells per day using systems such as the IonWorks HT . In a recent exciting development, voltage-clamp recordings can now be made from populations of cells (population patch clamp [PPC]) using the IonWorks Quattro system. 15 The measured ionic current is the sum of the individual contributing cells (up to 64) and is scaled (i.e., divided by 64) for comparison with single-cell measurements.
Here we report the application and validation of planar array electrophysiology techniques to assays for modulators of Ca 2+activated K + channels. Data from single-cell and populations of cells are compared and used to highlight the technical challenges in configuring these assays. Our findings demonstrate that PPC (IonWorks Quattro) is a powerful method for screening these targets and provides significant advantages over single-cell electrophysiology (IonWorks HT ) and other previously published approaches. Moreover, this work demonstrates for the 1st time the utility of PPC for ion channel activator assays and for non-voltage-gated ion channels.
MATERIALS AND METHODS

Cell culture and preparation
Chinese hamster ovary (CHO) cells stably expressing either human IK or hSK3 K + channels 16, 17 were maintained in T-175 (Corning 430641) tissue culture flasks at 37°C in a humidified environment containing 5% CO 2 in air. The cell culture media comprised Dulbecco's Modified Eagle Medium (Gibco, 21965-035) supplemented with 10% fetal bovine serum (Gibco, 10094-142), 1% penicillin-streptomycin (Gibco, 15140-122), 1% L-glutamine (Gibco, 25030-025), 1% nonessential amino acids (Gibco, 11140-035), and 1% geneticin (G418; Gibco, 10131-027) for selection. For the day of recording, cells were grown to 70% to 90% confluence in a T-175 flask.
Immediately prior to use, the cells were first washed with 4 ml of Versene (Gibco, 15040-033). Cells were gently lifted from the flask by incubating them in 2 ml Versene (6 min at 37°C) and then centrifuged (1000 rpm, 2 min). The resulting cell pellet was resuspended in 3 ml of the external buffer, composed of Nagluconate (120 mM), NaCl (20 mM), KCl (5 mM), MgCl 2 (1 mM), HEPES (10 mM), and CaCl 2 (2 mM), in double-distilled H 2 0, pH 7.3, with NaOH. The cell suspension was gently triturated for 1 min at a final density of approximately 1 × 10 6 cells/ml -1 .
Compound and reagent preparation
Test compounds were first solubilized in 100% DMSO and then plated on either 96-(Nunc, 249662) or 384-well (Greiner, 781280) microplates or, in some experiments, glass-coated plates (Sun Sri, 400 056). Liquid handling was performed either manually (multichannel pipettor) or with the aid of a Biomek FX for low-volume (<20 µL) work. For concentrationresponse curve analysis, compounds were plated at the highest concentration in either row H and diluted 1:3 up plate (8-point curves) or, in some experiments, in column 1 and diluted 1:3 cross plate (10-point curves). Columns 11 and 12 (of a 96-well plate) or 6 and 18 (of a 384-well plate) were used for high-(channel opener or vehicle) and low-(vehicle or channel blocker) control samples. All experiments were performed with compounds in a bulk solution of the external recording buffer, with a final assay concentration of 1% DMSO.
An internal recording buffer was prepared comprising K-gluconate (120 mM), KCl (20 mM), NaCl (5 mM), MgCl 2 (1 mM), HEPES (10 mM), and CaCl 2 (2 mM), pH to 7.2, with KOH (all Sigma-Aldrich), in double-distilled water. This solution was filtered. The permeabilizing reagent used for attaining the perforated patch clamp configuration was amphotericin (Sigma A-4888-1G), which was solubilized in 100% DMSO to a concentration of 100 mM with the aid of sonication and vortexing. Amphotericin was added to a 50-ml aliquot of the internal buffer to give a final concentration of 100 µM.
Planar array electrophysiology recording
All data were gathered on an IonWorks Quattro system 15 capable of operating in either single-cell or PPC recording modes. A fresh cell suspension was placed in the cell boat on the deck of the instrument, and the experiment was started within 2 min. Following a 10-min period for the cells to seal to the substrate, the amphotericin-containing internal solution was introduced and left to equilibrate for a further 4 min. During this time, the perforated patch clamp configuration was achieved with estimated access resistances of 5 to 10 MΩ. Cells were clamped at a holding potential of -90 mV for 30 s before ionic currents were measured using a combined step (0 mV, 100 ms) and ramp (-90 mV to +80 mV, 500 ms) protocol. Ionic currents were digitized and sampled at 10 kHz. Plates were read in half-at-once mode, in which the predrug and postdrug reads for the top half of the patch plate (rows A-D) were first read followed by the remainder of the plate (rows E-H). Test compounds were applied in a volume of 3.5 µL (1:3 assay dilution) for 240 to 600 s between the precompound and postcompound reads.
Population Patch Clamp K + + Channel Assays
Conventional patch clamp electrophysiology
Patch clamp electrophysiology methods were as described by Dale and others. 16 Cells plated on a glass coverslip were positioned in a recording chamber (0.5 ml) and superfused with an extracellular solution at a rate of 2 ml/min -1 . The standard extracellular solution contained KCl (144 mM), MgCl 2 (1 mM), CaCl 2 (2 mM), glucose (5 mM), and HEPES (10 mM). The pH was adjusted to 7.4 using KOH, and the osmolarity ranged from 290 to 310 mOsm. Patch pipettes (borosilicate glass) were pulled using a Sutter P-97 electrode puller and filled with an internal solution consisting of K-gluconate (144 mM), MgCl 2 (1.15 mM), EGTA (5 mM), CaCl 2 (2.06 mM), and HEPES (10 mM), yielding a free (unchelated) [Ca 2+ ] of 100 nM. The pH was adjusted to 7.25 using KOH, and the osmolarity ranged from 275 to 290 mOsm. When filled with internal solution, patch electrodes had tip resistances of 2 to 5 MΩ.
Currents were recorded using standard whole-cell voltageclamp recording techniques 18 at room temperature (21°C-23°C) using an Axopatch 200A amplifier. Signals were low-pass Bessel filtered at 2 kHz and digitized via a Digidata 1200 (Axon Instruments, Sunnyvale, CA) at a sampling frequency of 4 kHz. Voltage command protocols and data acquisitions were controlled using pClamp 8 software (Axon Instruments). Data were stored on the hard drive of a microcomputer (Vectra; Hewlett Packard, Palo Alto, CA). The series resistance did not exceed 10 MΩ, and voltage errors (80%-85%) were minimized with compensation circuitry.
Leak subtraction voltage-command protocols, such as P/4 (Axon Software), were not employed. Membrane potentials were corrected for liquid junction potentials offline. Drugs were applied through a fine needle positioned close to the cell via a series of gravity-fed reservoirs. Using this system, the dead volume was less than 50 µl, corresponding to a lag time of approximately 2 s.
Data analysis
All data analysis and presentation was performed using IonWorks software (version 1.7), Microsoft Excel (version 6.0), Spotfire DecisonSite (version 7.3), and Microcal Origin (version 5.0). K + channel signal isolation and signal validation, and the analysis therein, are described in the "Results" section. Where it was appropriate to calculate Z′ values, the method of Zhang and others was employed, 19 where Z′ = 1 -(3 × (SD low + SD high )/(mean low -mean high ). For the concentration-response curve analysis, the percentage of control data was fitted to a 4-parameter logistic equation of the order percentage of control = 100 × (1 + ([drug]/IC 50 ) p ) -1 , where IC 50 is the concentration of drug required to inhibit current by 50% and p is the Hill slope. The theoretical potassium equilibrium potential (E K ) was calculated from the Nernst equation,
where R is the ideal gas constant (8.31j/(mol-K)), T is the absolute temperature (273 + 25°C), and F is Faraday's constant 96485.3 C mol -1 .
RESULTS
Assay principle and preliminary signal validation
hIK (or hSK3) currents should appear as time-independent, non-voltage-dependent signals that simply follow the applied electrical driving force according to Nernstian principles. Under symmetrical K + conditions, this would equate to a linear signal reversing at 0 mV for a suitable applied voltage ramp. The conductance can be derived from the slope of the line. Unfortunately, however, this current would strongly resemble the large (non-IK) nonspecific leak current that occurs because of the low resistance electrical seals (<200 MΩ) with the IonWorks platform. In theory, the use of nonsymmetrical K + conditions (145 mM in, 5 mM out) circumvents this if currents are measured at 0 mV, the potential at which the nonspecific leak current is zero and K + currents appear as outward. Importantly, even if the nonspecific leak changes (i.e., the seal improves or worsens), within limits, the contaminating leak current at 0 mV will not. Of course, this theory is critically dependent on precise awareness and control of extraneous voltage offsets, such as liquid junction potentials.
To validate this theory, in pilot experiments in single-hole mode, we measured currents in hIK-expressing cells before and after addition of a known small-molecule channel activator, CCI7950 (chemical structure undisclosed, 10 µM; Fig. 1 ). Before addition, median seal resistances from 352 successful recordings (of 384, 92%) were 192 MΩ (range = 21-412 MΩ). With the leak subtraction facility disabled, the observed current evoked by a fast voltage ramp (-90 to +80 mV, 500 ms) was linear, of low amplitude at 0 mV (125 ± 12 pA), and reversed close to 0 mV (-3 mV). These parameters were highly stable following addition of the drug vehicle (resistance 178 MΩ, 148 ± 18 pA at 0 mV, E rev -2 mV). Although the stability of the signal at 0 mV was not unexpected (because it should be leak independent), we also observed that the pre:post (vehicle) signals across the entire voltage range were also highly stable. For 173 cells, the mean and SD ratio for the post:pre current at -90 mV was 1.02 ± 0.11 and at + 60 mV was 1.01 ± 0.12 (Fig. 2) . On 11% of occasions (18 of 173), there was a marked (>1.5-fold) increase in the current (and drop in resistance) at +60 mV following vehicle addition: One explanation for this is that the channels in these cells became activated over the time of the experiment, possibly because of Ca 2+ entry. Despite this and overall, drug responses could be isolated across the entire voltage range with some confidence by subtracting the predrug signal.
Following addition of CCI7950 (3-min incubation time), marked increases in current were observed at 0 mV in 185 of 192 cells, ranging from 200 pA to >6 nA (median = 2.8 nA). The membrane resistance fell sharply (<50 MΩ), and the reversal potential moved toward more negative values (-90 to -100 mV), consistent with the opening of K + channels. With the knowledge that the pre to post compound signals were stable, subtraction of the predrug from the postdrug signal allowed isolation of the IK current ( Fig. 1) . This current exhibited slight inward rectification and reversed close to the theoretical K + equilibrium potential (measured -80 mV, predicted -84 mV).
Activator concentration-response curve analysis in singlehole mode
Preliminary experiments aimed at constructing concentrationresponse curves for known hIK channel activators highlighted fundamental challenges in single-hole mode. A large heterogeneity in the magnitude of response of individual cells to the same test compound was observed, ranging from no response to currents >6 nA at 0 mV. In the absence of an ability to add a 2nd test agent for normalization, preferably a high concentration of a standard activator, it proved impossible to discern nonresponding cells from nonexpressing ones. Even with data normalization to pooled high and low control cells, without a large number of replicates to accommodate for this cell-to-cell variation, concentration-response curves could not easily be generated (Fig. 3A, C) . This is not the case for voltage-gated blocker assays that have been previously described in which the presignal current can be used to filter out nonexpressors and the floor of 100% drug inhibition is known. 12, 20 
Activator concentration-response curve analysis in PPC mode
The ability to record an average signal from a population of cells within a well with PPC provides an opportunity to dramatically minimize interwell variance. In this mode, the success rate for recordings (hIK) was significantly higher than with single-hole recordings (14,096 from 14,208 attempts [37 plates]: 99.2%). The predrug seal resistance values were slightly lower but more consistent (median = 87 MΩ, SD = 23 MΩ; post:pre = 1.02 ± 0.11 [all wells]), as expected from PPC theory (Fig. 4) . 15 As with the single-hole experiments, for the predrug reads, only small currents (median = 132 ± 8 pA) were observed at 0 mV, and the signal E rev was -2 mV. Strikingly, addition of a supramaximal concentration of channel activator evoked a marked outward current in all wells tested, which was highly consistent from well to well (2.8 ± 0.4 nA; Fig. 3B, D) . From 6 plates, the Z′ values (opener v. DMSO vehicle) ranged from 0.20 to 0.75. Concentration-response curves could be readily constructed, either with or without normalization to low and high control values, with consistent pEC 50 (6.2 ± 0.1) and Hill slope values (mean = 1.1, range = 0.8-1.3). Similar success rates and precision were observed for hSK3.
Biophysical and pharmacological validation of PPC signals for hIK and hSK3
For both hIK and hSK3, the absolute pEC 50 values and the rank order of agonist potency of a range of known channel activators (1-EBIO, DC-EBIO, NS309, GW275919X, CCI7950) were highly consistent from plate to plate (SD values <0.3) and correlated well with data obtained by conventional patch clamp (see Fig. 5 and Table 1 ). 4, 21 The correlation coefficients were 0.99 (5 compounds) and 0.98 (4 compounds) for hIK and hSK3, respectively (both p < 0.001). Neither the specific IK inhibitor, TRAM-34 (1 µM) 22 nor the specific SK(3) channel blocker apamin (30 nM) 23 had any effect per se on the small background currents in the hIK and hSK3 cell lines, providing further support that these are nonbiological leak currents (and that the voltageoffset corrections are true). In contrast, each inhibitor produced channel-specific concentration-related inhibition of responses to activator compounds ( Figs. 6 and 7) . For hIK, the IC 50 value for inhibition of CCI7950 (1 µM for hIK and 3 µM for hSK3) by TRAM-34 was 312 nM (3 curves from 1 assay plate), close to the published value for block of IK when activated by Ca 2+ (25 nM). 22 There was evidence of a weak voltage-dependent block; at 1 µM TRAM-34, the current at +60 mV was inhibited by 83% ± 4% compared to 72% ± 4% at 0 mV (p < 0.05, paired t-test). Apamin did not block hIK at concentrations up to 100 nM (7% ± 3%, n = 3). For hSK3, the IC 50 value for inhibition of CCI7950 (10 µM) by apamin was 2.9 nM (1.3-6.4, n = 4), which is also similar to previously published values (0.9 nM). 16 TRAM-34 did not block hSK3 at concentrations up to 1 µM (9% ± 3%, n = 3).
As a final signal validation check in PPC mode, we analyzed the activator-induced changes in reversal potential in more detail. At an EC 100 concentration (10 µM) and in 5 mM external K + , the signal reversal potential was -80 mV, close to the calculated K + equilibrium potential of -84 mV. The reversal potential was critically dependent on the external K + concentration. From 4 cells each, the mean reversal potentials were -80 mV, -48 mV, -30 mV, and -22 mV at K + concentrations of 5 mM, 14 mM, 32 mM, and 50mM, respectively (Fig. 8) . These values closely followed the predictions of the Nernst equation 
Assay robustness and screening performance
To test robustness and screening performance for the hIK activator assay, 704 test compounds arrayed on 384-well compound plates were screened in duplicate (4 plates; Fig. 9 ) at a final assay concentration of 10 µM. High (standard activator) and low (DMSO 1%, vehicle) controls were added to columns 6 and 18. Each of these plates was randomly spiked with known active samples at low (EC 25 -EC 50 ) and high (EC 100 ) concentrations. The predrug signal value at 0 mV was subtracted from the postdrug signal and normalized to the high and low control values. The Z′ values for the 4 plates ranged from 0.6 to 0.7 (median = 0.7). There was an excellent correlation (R 2 = 0.98) between the percentage activation values for the replicate test occasions (Fig. 9) . The statistical cutoff for activity was 9% activation on the 1st test occasion and 8% on the 2nd occasion. All of the spiked compounds were detected on 1 or both test occasions. Excluding these, 11 statistical actives were identified on the 1st test occasion (hit rate = 1.5%) and 7 (hit rate = 0.9%) on the 2nd. There were 4 duplicate actives. We reanalyzed the same data but this time without subtracting the predrug values. With this approach, we could discern no meaningful loss in assay quality or precision.
DISCUSSION AND CONCLUSIONS
Several lines of evidence support our proposal that signals arising from recombinant Ca 2+ -activated K + channels can be isolated using the high-throughput electrophysiology methods we describe. First, addition of a known channel activator evoked an outward current at 0 mV in either hIK or hSK3 stably transfected, but not wild-type, CHO cells. Second, the reversal potential of this signal was close to that predicted by the Nernst equation for a K + -selective membrane, across a range of external K + concentrations. Third, the absolute and relative potencies, against both hIK and hSK3, of a range of known activators were close to those obtained using conventional patch clamp electrophysiology. Finally, the evoked signals could be potently and specifically inhibited by the known channel blockers apamin and TRAM-34. This ability to successfully and fully isolate IK and hSK3 conductances was initially a little surprising given the technical challenges of the platform. Large (nonbiological) leak currents (5 nA at +100 mV) arise from the comparatively low seal resistances (200 MΩ v. 1-10 GΩ by conventional patch clamp) obtained by IonWorks. This leak current, which cannot be easily removed by the standard subtraction method in the software, will contaminate the K + current of interest. Moreover, the lack of temporal signature of the current (e.g., activation/inactivation/deactivation kinetic) makes it harder to confidently distinguish the true biosignal from artifact. Another confounding factor is the amphotericin-perforation method for electrical access to the cell interior, which does not allow for close control and buffering of the intracellular Ca 2+ concentration. Importantly, we observed that in the absence of a channel activator, the basal current was extremely low (indicating that free [Ca 2+ ] i must be <100 nM), which allowed us to estimate the leak current from the precompound signal. This signal was remarkably stable over time, as determined from a comparison of the post-(vehicle) to precompound ramp, and thus we could confidently remove leak by subtracting the precompound signal. It is worth noting that even if this were not true, the currents measured at 0 mV per se are (largely) independent of the amount of leak current, which reverses at this potential (i.e., is zero). A major finding of this work was the extent to which the PPC method proved enabling for the activator assays. In singlehole mode, despite the fact that >90% of the cells expressed IK currents >500 pA at 0 mV, the cell-to-cell heterogeneity was too great to readily resolve concentration-response curves. In contrast, the signal averaging obtained by recording from multiple cells within a well reduced the heterogeneity to an acceptable level (coefficient of variation <10%) and truly transformed the assay. It proved straightforward to assemble 384-well activator assays for both hIK and hSK3 with Z′ values consistently greater than 0.5 in PPC mode. For concentration-response curve analysis, the active compounds we selected (published and unpublished activators) yielded data that could readily be fitted using standard 4-parameter logistic functions, with few if any outlier data points. In primary screening mode, the hIK assay performed with high precision and a low detection cutoff (<10%); there was an excellent correlation (R 2 = 0.98) between replicate test occasions for 704 samples analyzed at a single concentration, and all spiked samples were identified as active. The low hit rate (<2%) confirms our expectation that this assay will not yield significant numbers of false-positive hits. Interestingly, when these screening data were reanalyzed without subtraction of the predrug sweep V metric values, there was no reduction in data quality, indicating that the predrug sweep is not absolutely required. This indicates that a novel mix-and-read type electrophysiology assay format should be possible, in which compounds are added to cells offline and then scanned once for ionic currents after a suitable equilibration period. Such an approach is not possible with the existing platform configuration but could be enabled. The major advantages of mix and read over the current protocol would be speed (reduced plate-read times) and ease of use.
Overall, we conclude that the hIK and hSK3 PPC electrophysiology assays we have configured are meaningful, precise, and amenable to a structure-activity relationship and random (hit finding) screening. The assay principles are generic and could be applied to further SK channel family members and other leaklike channels (e.g., twin-pore K + channels), both in activator or blocker modes alike. Although these assays are not ultra high throughput, they provide sufficient speed (∼2000 compounds per day) to enable the rapid screening of targeted compound sets (e.g., 10,000-20,000) as well as the capacity to support large medicinal chemistry campaigns. The direct nature of PPC measurement is advantageous over existing methods in several ways: The signal is real time and linear with channel function, it does not suffer from quenching or autofluorescent artifacts, and it offers significantly greater precision and throughput than the 1stgeneration IonWorks HT single-cell detection. Thirteen wells were randomly spiked with either a low (EC 25 -EC 50 ) or high (EC 100 ) concentration of known activator. The correlation coefficient between the 2 test occasions was 0.98, and the statistical cutoff for activity based on the precision of the high and low control values was 9% (occasion 1) and 8% (occasion 2; shown by the dotted lines).
